Metropolis Healthcare Share Price
590.35-1.55 (-0.26%)
+6.92% past 1 Year
Metropolis Healthcare Limited is engaged in the business of providing pathology and related healthcare services. The profile comprises of a variety of test combinations which are specific to a disease
Corporate filings & documents
Announcements
Transcript of Investors & Analyst Meet held on Thursday August 27 2026
1 day agoTranscript of Investors & Analyst Meet held on Thursday August 27 2026
1 day agoAudio recording of the Investors & Analyst Meet
1 week agoDisclosure under Regulation 30 of SEBI Listing Regulations
1 week agoDisclosure under Regulation 30 of SEBI Listing Regulations
1 week agoInvestor Presentation
1 week agoInvestor Presentation
1 week agoDisclosure under Regulation 30 of SEBI Listing Regulations
2 weeks agoDisclosure under Regulation 30 of SEBI Listing Regulations
2 weeks agoSchedule of Analyst / Institutional Investor Meeting
2 weeks agoSchedule of Analyst / Institutional Investor Meeting
2 weeks agoScrutinizers Report for the 26th Annual General Meeting
2 weeks agoScrutinizers Report for the 26th Annual General Meeting
2 weeks agoProceedings of the 26th Annual General Meeting of the Company
2 weeks agoProceedings of the 26th Annual General Meeting of the Company
2 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Metz Advisory LLP & PACs
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Metz Advisory LLP & PACs
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Duru Shah Family Trust & PACs
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Duru Shah Family Trust & PACs
3 weeks agoTranscript of Q1 FY27 earnings conference call held on Wednesday August 05 2026
3 weeks agoTranscript of Q1 FY27 earnings conference call held on Wednesday August 05 2026
3 weeks agoLink of audio recording of the earnings conference call held on August 05 2026
4 weeks agoLink of audio recording of the earnings conference call held on August 05 2026
4 weeks agoNewspaper Publication
4 weeks agoNewspaper Publication
4 weeks agoInvestor Presentation for the quarter ended June 30 2026
1 month agoInvestor Presentation for the quarter ended June 30 2026
1 month agoPress Release
1 month agoPress Release
1 month agoUnaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2026
1 month agoUnaudited Standalone and Consolidated Financial Results for the quarter ended June 30 2026
1 month agoOutcome of Board Meeting
1 month agoOutcome of Board Meeting
1 month agoGrant of Stock Benefits
1 month agoGrant of Stock Benefits
1 month agoAllotment of 18 700 equity shares under the Metropolis-Restrictive Stock Unit Plan 2020
1 month agoAllotment of 18 700 equity shares under the Metropolis-Restrictive Stock Unit Plan 2020
1 month agoThe Company will participate in the Q1FY27 earnings conference call (i.e. post earnings/quarterly call) organized by JM Financial Institutional Securities Limited on Wednesday August 05 2026 at 09:00 a.m. (IST) to discuss the financial results of the Company for the quarter ended June 30 2026
1 month agoThe Company will participate in the Q1FY27 earnings conference call (i.e. post earnings/quarterly call) organized by JM Financial Institutional Securities Limited on Wednesday August 05 2026 at 09:00 a.m. (IST) to discuss the financial results of the Company for the quarter ended June 30 2026
1 month agoMetropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30 2026
1 month agoMetropolis Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 inter alia to consider and approve the un-audited standalone and consolidated financial results for the quarter ended June 30 2026
1 month agoNewspaper Advertisement
1 month agoNewspaper Advertisement
1 month agoLetter to Shareholders containing weblink of Annual Report for the financial year 2025-26 and 26th Annual General Meeting
1 month agoLetter to Shareholders containing weblink of Annual Report for the financial year 2025-26 and 26th Annual General Meeting
1 month agoBusiness Responsibility and Sustainability Report for the financial year 2025-26
1 month agoBusiness Responsibility and Sustainability Report for the financial year 2025-26
1 month agoNotice of the 26th Annual General Meeting for the financial year 2025-26 to be held on August 18 2026
1 month agoNotice of the 26th Annual General Meeting for the financial year 2025-26 to be held on August 18 2026
1 month agoAnnual Report for the financial year 2025-26
1 month agoConcalls & investor presentations
Aug 2026
ConcallPresentation
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Nov 2025
ConcallPresentation
Aug 2025
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Aug 2022
ConcallPresentation
May 2022
ConcallPresentation
May 2022
ConcallPresentation
Feb 2022
Nov 2021
ConcallPresentation
Nov 2021
ConcallPresentation
Aug 2021
ConcallPresentation
May 2021
ConcallPresentation
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
Nov 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-05-19
Dividend
1.0
2026-03-20
Bonus
3:1
2025-11-11
Dividend
4.0
2023-11-17
Dividend
4.0
2023-02-23
Dividend
8.0
2021-02-17
Dividend
8.0
2020-02-13
Dividend
8.0
Company details
Registered office
4th Floor, East Wing, Plot-254 B Nirlon House, Dr. Annie Besant Road Worli Mumbai Maharashtra PIN: 400030 Tel No: 022 6258 2810 / 8422 801 801 Fax No: NULL Email: [email protected] / [email protected] Internet: www.metropolisindia.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Sushil Shah, Non Independent & Non Executive Director
Ameera Shah, Chairperson
Surendran Chemmenkotil, Managing Director
Hemant Sachdev, Non Independent & Non Executive Director
Aparna Rajadhyaksha, Non Independent & Non Executive Director
Vivek Gambhir, Non Executive Independent Director
Subramanian Ranganathan, Non Executive Independent Director
Sanjay Bhatnagar, Non Executive Independent Director
Purvi Sheth, Non Executive Independent Director
Rehan Khan, Non Executive Independent Director
Kamlesh Kulkarni, Head-Legal, Company Secretary & Compliance Officer
Details
BSE 542650
NSE METROPOLIS
ISIN INE112L01020